chrisvoncsefalvay/vaers-outcomes huggingface dataset:
~2 weeks after receiving second dose of Moderna vaccine, pt. developed ringing in ears, drastic hearing loss in right ear,  dizziness, nausea (w/emesis), achy muscles and headache. PCP diagnosed pt. with Meniere's disease. Since initial onset, symptoms have improved but patient is still not fully back to normal (some hearing loss, achy muscles and dizziness persist).
A few hours after first dose I began having a metallic taste in mouth. This lasted for several hours, even through sleep. Also had zero food or appetite all day, despite trying, even after metallic taste dissipated.  FYI:  my boyfriend, who completed both shots of this same brand, said he also had weird taste in mouth.
Pt states she got a rash from injection site to elbow and around back side of arm and down side. She states that is itches, does not hurt and is mildly relieved by benadryl gel and tablets. Office told pt to increase benadryl doses/day, if not better by tomorrow will send her a steroid.
Patient received the MCV4 and a PPD Test today. He first received the MCV4 and had no symptoms that he was going to faint. After the PPD Test, the mom stated that she was surprised that he did not faint because he had just fainted a few weeks before because of pain. I was giving him a paper towel for the blood on his PPD test when he stated that he felt like he was going to faint. His mother and I reached him right as he fainted. While he was experiencing this episode, which lasted around a minute or two, his whole body tensed up causing his legs to stiffen, arms to draw in, his back to arch and he was holding his breath. A few seconds after his back arched it relaxed and his head was hanging down. Around 5 seconds after this he took a breath. He also urinated on himself while he was not conscious. When he regained consciousness, he started to throw up. I gave him a wet paper towel, some water and offered a sucker. After a few minutes he stated that he felt like he was going to faint again, so with the assistance of his mother we moved him to the bed. I went to get RN after he was on the bed and stated that he did not feel like he was going to faint again. After she was in the room with him, I went to get Dr. to see him.----He was pallorous, yawning and shivering, but alert. He related a recent hx of a similar episode triggered by a sudden, sharp pain upon turning his neck in a movie theater. His mother had taken him to the emergency room after that event. He was kept supine in clinic for approximately 40 minutes, after which he was able to sit and drink a bottle of water the Dr. gave him. After a few minutes more the Dr. ambulated him in the hallway without difficulty and he experienced no symptoms. He was well enough to be dismissed. Precautions with dehydration risk, possible future risk with venipuncture or injections, and provided them with a printout on vasovagal syncope from the Clinic website. All questions were answered to their satisfaction.
Moderna vaccine Day one, redness and tender at injection site  By day 2 the site was inflamed, red, hot to touch, and a large firm lump about the size of a quarter. Day 3-5 similar symptoms to day 2 however, the lump was larger, painful to touch and at times itchy. Theses symptoms overall lasted 2 weeks. The lump got smaller in size and the itch increased.
Pediatric dose given to an adult; Pediatric dose given to an adult; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 50-year-old female patient who received HBV (Engerix B pediatric) (batch number EM9E4, expiry date 17th February 2025) for prophylaxis.   On 20th February 2023, the patient received the 1st dose of Engerix B pediatric. On 20th February 2023, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK receipt date: 24-Feb-2023 Reporter's comment: The reporter consented to follow-up by email. Additional supportive information: An adult patient received a pediatric dose of Engerix-B, which underdose and adult use of a child product.
Covid arm.  7 days after injection arm where shot was administered became swollen, red, hot, painful and itchy.  Lasted for 3 days.
Work up on 12/31/2014 to horrific pain in left shoulder, neck and arm.  Could not straighten head.
Shaking, Dizziness, and Weakness about 17 hours after the injection of Moderna Covid-19 Bivalent Booster
15 minutes after vaccine adm. C/O head feels funny, tingling hands and tongue, dizziness, trembling. BP 140/100. P100. seen in ER, client reports MD said anxiety. Client reported feeling light headed one hour after first Hep B injection.
Client states after she gave herself  an injection of Saxenda  this morning (2/10/2021) she had a reaction at the site of injection(Right Thigh)  - Became swollen.  She states she has never had a reaction like that before and she received the COVID 19 vaccine yesterday.  She feels like this is related to having the vaccine yesterday.   She took Zyrtec  and after an hour the site was normal
I'm still overly fatigued; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In July 2022, the patient received the 1st dose of Shingles vaccine. In July 2022, less than a week after receiving Shingles vaccine, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was not recovered/not resolved.   It was unknown if the reporter considered the fatigue to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 27-Jul-2022 Reporter's Comments:  This case was received from consumer via interactive digital media. The patient was curious and he/she got the first dose a week ago.  The patient still overly fatigued The follow-up would not possible as no contact details were available.
Sudden nausea and vomiting the morning after vaccine (8:30am; got vaccine at 6:10 the night prior). After getting sick, suddenly got very lightheaded and dizzy and fainted in shower. Awoke and had severe fever and headache the rest of the day after vaccine (102°F fever).
Relapse of Fibromyalgia; Bad balance lasted 3 days; muscles in my legs are tense and tight; A lot of pain walking and standing; This is a spontaneous report from a contactable consumer. A 73-year-old male patient received BNT162B2 (solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Mar2021 10:45 (Batch/Lot Number: Er2613) as dose 2, single for covid-19 immunisation. Medical history included fibromyalgia once in 1980, once in 2000. Concomitant medication included diazepam (VALIUM); ibuprofen (MOTRIN [IBUPROFEN]); alprazolam (XANAX) taken for an unspecified indication, start and stop date were not reported. The patient previously took BNT162B2 for covid-19 immunisation on 12Feb2021 at the age of 73-year-old, neurontin and experienced Allergy, quinine sulfate and experienced Allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The patient did receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had severe Fibromyalgia conditions twice before, once in 1980, once in 2000 and now after 2nd Pfizer Vaccine. Patient have short relapses for a few days every so often, but symptoms do go away. His bad side effects had him grabbing on to walls and furniture to walk. Bad balance lasted 3 days. The muscles in his legs are tense and tight. A lot of pain walking and standing. It was going on to 3 weeks since my 2nd Vaccine and was still hurting. He was taking the only medications that have a beneficial effect on his body. The patient did not receive treatment for the adverse events. Outcome for the events was not recovered.
Roughly 2 weeks after my first vaccine, I noticed a lump on the side of my right breast, underarm area. It only lasted a couple days, but since then has  come back randomly.
Patient had itchy ear, sore throat, and shortness of breath after receiving Gardasil (first dose). Pt at home when reaction occurred and took Zyrtec. Rxn resolved
Itchy rash; This case was reported by a pharmacist via call center representative and described the occurrence of itchy rash in a 20-year-old female patient who received Herpes zoster (Shingrix) (batch number KC9C4, expiry date 30th March 2020) for prophylaxis.   The patient's past medical history included lymphadenectomy (lymph nodes removed in the past on her left arm).   On 30th April 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 30th April 2019, 30 min after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the outcome of the itchy rash was unknown.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix in the left arm. The patient experienced itchy rash from her elbow to her shoulder on the left arm. No further details were provided.
DIARRHEA, WENT TO THE BATHROOM 4 TIMES; NAUSEA; BODY WAS UNCOMFORTABLE; FEELING OF 5TH DIMENSION, LIKE FLOATING IN THE SKY; DID NOT FEEL LIKE DOING ANYTHING; CHILLS AS DAY WENT ON; WOKE UP WITH NOT FEELING WELL/ GENERAL MALAISE; This spontaneous report received from a patient concerned an 83 year old white male of unspecified ethnic origin The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received vaccination with covid-19 vaccine(dose number in series 1) (suspension for injection, route of admin not reported, and batch number were not reported) dose was not reported, administered on 07-MAY-2021 for prophylactic vaccination. No adverse event reported following vaccination with covid-19 vaccine. The patient received covid-19 vaccine (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, administered on 04-NOV-2021 12:30 for prophylactic vaccination. No concomitant medications were reported. On 05-NOV-2021 Patient began to experience side effects. woke up not feeling well 12th at night, chills as day went on, nausea, but no vomiting. Claimed that he did not feel body pain, but stated that body was uncomfortable. Patient felt that he was in a 5th dimension, like he was floating in the sky. He did not feel like doing anything that day. On 06-NOV-2021, nausea and chills stopped, but general malaise continued. Night from Saturday 06-NOV-2021 to Sunday 07-NOV-2021, patient had diarrhea an went to the bathroom 4 times. He had not taken anything to stop the diarrhea and the diarrhea is resolving itself. Nothing else was taken to relieve other symptoms. The action taken with covid-19 vaccine was not applicable. The patient recovered from body was uncomfortable, and feeling of 5th dimension, like floating in the sky, and chills as day went on, and nausea on 06-NOV-2021, was recovering from diarrhea, went to the bathroom 4 times, had not recovered from woke up with not feeling well/ general malaise, and the outcome of did not feel like doing anything was not reported. This report was non-serious.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021 at 10:25 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 10:26 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 66.79 for dose administered on 03-Mar-2021 and 66.86 for dose administered on 31-Mar-2021.  No concomitant medications were reported. Batch number 014M20A underwent temperature excursion on 03-Mar-2021 with temperature 51 degrees Fahrenheit at 09:00 AM, 34 degrees at 10:00 AM and 35 degrees at 01:00 PM This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 03-Mar-2021.  Batch number 030B21A underwent temperature excursion on 31-Mar-2021 with temperature 32 degrees Fahrenheit from 08:00 AM to 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 31-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Slight dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Slight dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Slight dizziness). At the time of the report, DIZZINESS (Slight dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up received and contain significant information. Patient contact details and start date of the vaccine, second dose information updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Hay fever; This spontaneous case was reported by a patient and describes the occurrence of SEASONAL ALLERGY (Hay fever) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    Patient had no ongoing medical conditions.  Previously administered products included for Product used for unknown indication: COVID vaccine (Patient have had the COVID vaccine and three boosters.). Past adverse reactions to the above products included No adverse event with COVID vaccine.   On 18-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Oct-2022, the patient received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEASONAL ALLERGY (Hay fever). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Hay fever, at an unspecified dose and frequency. At the time of the report, SEASONAL ALLERGY (Hay fever) outcome was unknown.            No relevant concomitant medications were reported.   Patient had never contracted COVID and his last dose was of Pfizer.
A report was received from a health care professional on 12/9/03 concerning a and a half year old male vaccinee who inadvertently received Fluvirin on 12/9/03. On 12/9/03, the vaccinee inadvertently received Fluvirin vaccine. No adverse symptoms had been reported at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.            No concomitant and treatment information were reported by the reporter   This case was linked to MOD-2021-344114 (Patient Link).
With the first Pfizer dose on 02/16/21, I experienced immediate pain at the injection site.  This pain increased and became increasingly severe and extremely intense within 5 hours of the vaccine.  At that time other symptoms began to develop, including a very severe headache (crown/back of head), swollen glands and stiff neck, rapid heartrate, shortness of breath.  These symptoms lasted at an intense level for 2 days, and at a moderate level for a total of 14 days (last symptoms were observed on 02/23/2021).  Please also note that I started my period that month on 02/17/2021.  My second Pfizer dose was on 03/9/2021, 1:40pm.  (COVID19 Pfizer~BioNTech, Lot EN6205, intramuscular, left arm). I experienced mild pain at the injection site within 5 hours of the vaccine.  24 hours after the second dose I began to develop moderate/severe symptoms including headache (crown/back of head), swollen glands and stiff neck, rapid heartrate, shortness of breath.  These symptoms lasted at a moderate level for a total of 14 days (last symptoms were observed on 03/23/2021.  Please note that I started my period that month on 03/17/2021.  This month I started my period 2 days later than usual on 04/14/2021.  In addition to my regular menstrual symptoms (including migraine temporal headache and mild cramps), I experienced additional symptoms starting on 04/15/2021.  These included moderate/severe headache (crown/back of head), swollen glands and stiff neck, rapid heartrate, and shortness of breath.  These symptoms are still present at a moderate level today, 04/22/2021.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 28-year-old male. Neither medical history nor concomitant medications were reported. On 26-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 12-May-2009: Product Complaint Investigation results.
Although I had completed the Shingrix series on 12/22/202 I noticed a recurrence of shingles on my left inner thigh on 4/26/2021.  I recognized it because I had had 2 previous episodes in the exact same location,  (7/15/29 and 4/15/2020 , both treated with Valtrex). These episodes prompted me to get shingles vaccine. As of this date, shingles are resolving without medical attention. I am reporting this occurrence because I noticed similar  reports in the media regarding shingles after covid vaccination.
Employee with low grade fever, chills and shaking starting at 2am.  Tmax at 5:30 am of 101.2.  Self medicated with Motrin with some improvement of symptoms.
severe fever; chills; joint pain; muscle pain; extreme headaches; constipation; frequent urination; extremely tired; very severe rash/systemic rash/very bad, extreme rash/ rashes all over my body; nausea; diarrhea; rapid heart beat at times; extreme dizziness; Severe allergic reactions; Many allergic reactions; This is a spontaneous report from a contactable consumer (patient). A 75-years-old patient of an unspecified gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot Number: EW0182, Expiry Date: Unknown) via an unspecified route of administration, administered in Arm Left on 27Jul2021 (at the age of 75-year-old) as dose 1, single for COVID-19 immunization. No Medical history was reported. The patient's concomitant medications were not reported. On an unknown date in 2021, the patient had severe allergic reactions to first dose of the Pfizer vaccine. How do patient report the allergies?. The patient treatment included very many allergic reactions, I have taken Benadryl allergy medication, it was an over the counter product. The patient stated that have not seen a medical doctor yet (not clarified further). It was stated that sever fever began on the evening of 27Jul2021, I was at home. Patient further stated, "I had severe fever, chills, joint pain, muscle pain, extreme headaches, constipation, frequent urination, extremely tired and a very severe rash which I have had, nausea, diarrhea and a rapid heart beat at times in 2021. The worst which still remains was the 'systemic rash' (not clear), very bad, extreme rash in 2021 and was not going to take the second dose, it was on 18Aug2021, I need to know how to cancel that. The patient wanted to add that had extreme dizziness and the rashes all over my body in 2021." The patient received treatment with Tylenol for all events. Reporter seriousness for the events was Unspecified. Outcome of the event severe rash/systemic rash/very bad/extreme rash/ rashes all over my body was not recovered and outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.